Inmunología, Oftalmología y ORL
Departamento
MANUEL
PRAGA TERENTE
Profesor emérito
Publicaciones en las que colabora con MANUEL PRAGA TERENTE (19)
2024
-
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis
Kidney International, Vol. 105, Núm. 1, pp. 177-188
-
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International
2023
-
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
Kidney360, Vol. 4, Núm. 5, pp. 659-672
-
Thrombotic microangiopathy in patients with malignant hypertension
Nephrology Dialysis Transplantation, Vol. 38, Núm. 5, pp. 1217-1226
2022
-
C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies
Nephrology Dialysis Transplantation, Vol. 37, Núm. 11, pp. 2128-2137
-
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746
-
Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy
Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 6, pp. 1137-1153
-
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280
2021
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2020
-
Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease
Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298
-
Update on C3 Glomerulopathy: A Complement-Mediated Disease
Nephron, Vol. 144, Núm. 6, pp. 272-280
2019
-
The role of complement in IgA nephropathy
Molecular Immunology, Vol. 114, pp. 123-132
2018
-
CD19+ B-cells, a new biomarker of mortality in hemodialysis patients
Frontiers in Immunology, Vol. 9, Núm. JUN
2017
-
Elevated factor H–related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy
Kidney International, Vol. 92, Núm. 4, pp. 953-963
-
The presence of pretransplant antiphospholipid antibodies iga anti-b-2-glycoprotein i as a predictor of graft thrombosis after renal transplantation
Transplantation, Vol. 101, Núm. 3, pp. 597-607
2015
-
Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I
Journal of the American Society of Nephrology, Vol. 26, Núm. 3, pp. 735-745
2012
-
IgA antibodies against Β2 glycoprotein i in hemodialysis patients are an independent risk factor for mortality
Kidney International, Vol. 81, Núm. 12, pp. 1239-1244
1997
-
Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis
Nephrology Dialysis Transplantation, Vol. 12, Núm. 12, pp. 2576-2579
1990
-
SINDROME DE GOODPASTURE Y GLOMERULONEFRITIS MEMBRANOSA
Nefrologia, Vol. 10, Núm. 1, pp. 84-89